Novavax Inc vs Realty Income Corp — how do they compare? Novavax Inc trades at $7.97 (market cap $1.31B), while Realty Income Corp trades at $61.96 (market cap $58.56B). The key difference: Realty Income Corp is far larger — about 44.7× Novavax Inc's market cap, and Realty Income Corp pays a 5.25% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | O | |
|---|---|---|
Market Cap | $1.31B | $58.56B |
Sector | Health | Real Estate |
52-Week High | $11.19 | $67.56 |
52-Week Low | $6.22 | $55.93 |
Enterprise Value | $889.30M | $89.19B |
Dividend Yield | — | 5.25% |
Trailing returns across standard periods
Latest headlines on both assets
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.
Read more on O →